In this podcast, Charlotte M. Rolle, MD, MPH, discusses her team's research that evaluated the efficacy and safety of switching HIV treatment using
bictegravir/emtricitabine/tenofovir alafenamide to...
In this podcast, William Schaffner, MD, discusses recent updates to the Advisory Committee on Immunization Practices’ (ACIP) immunization recommendations in adults aged 65 or older, including pneumococcal,...
In this episode, C. Buddy Creech, MD, MPH, speaks about his team’s research titled “Safety of Live Attenuated Influenza Vaccine in Children With Asthma,” including supply chain issues with influenza...
In this podcast, Daniel Kuritzkes, MD, speaks about new medications available, choosing a new regimen for, and defining patients with HIV and limited treatment options. Dr Kuritzkez also participated in a...
In this podcast, Charles Flexner, MD, speaks about the current state of long-acting agents for the management of patients with HIV, HIV prevention and vaccines, and HIV pathogenesis and cure. Dr...
In this podcast, Charles Flexner, MD, speaks about a clinician's approach to managing a patient with HIV and limited treatment options, including choosing a new treatment regimen, understanding the...
In this podcast, Christian Sandrock, MD, MPH, talks about how the causative agents of community-acquired bacterial pneumonia (CABP) are identified and how patient characteristics and type of bacteria...
In this podcast, John Harrington, MD, speaks about the “triple threat” of viral respiratory infections in children during the winter of 2022-2023, including COVID-19, influenza, and respiratory syncytial...
In this podcast, William Schaffner, MD, discusses new data from the Centers for Disease Control and Prevention that suggest COVID-19 infections are close to 140 million. He also discusses the focus for the...
In this podcast, Frank LoVecchio, MD, discusses typical and atypical presentations of community-acquired bacterial pneumonia (CABP), as well as important considerations for health care providers when...
